TP53 and neuroblastoma: The specific MDM2 inhibitor, Nutlin-3, which blocks the interaction of p53 with MDM2, has been shown to sensitize chemotherapy-induced apoptosis in NB by reactivation of the p53 pathway [31,42,43,44].